The obesity paradigm and outcome after STEMI: good news for all patients with overweight and moderate obesity - Top-Institutions - MDSpire

The obesity paradigm and outcome after STEMI: good news for all patients with overweight and moderate obesity

  • By

  • Wolfram Doehner

  • October 16, 2025

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Cardiology
    • Cardiovascular Research
    • Interventional Cardiology

  • #2

    Brigham and Women's Hospital
    Brigham and Women's Hospital

    Boston, MA

    Key Differentiators

    • Cardiology
    • Epidemiology
    • Preventive Medicine

  • #3

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Cardiology
    • Cardiovascular Surgery
    • Obesity Medicine

  • #4

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Cardiology
    • Cardiovascular Epidemiology
    • Metabolic Medicine

  • #5

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Cardiology
    • Obesity Research
    • Clinical Epidemiology

Original Source(s)

The obesity paradigm and outcome after STEMI: good news for all patients with overweight and moderate obesity

  • by Wolfram Doehner

  • October 16, 2025

Related Content

Top 10 States With Rising Demand for Physicians

These 10 states report physician shortages, projected physician supply gaps, or physician-to-population ratios below national benchmarks.

The Impact of Metabolic Bariatric Surgery on Inflammatory Bowel Disease Risk and Outcomes in Adults With Obesity: a Propensity-matched, Nationwide, Analysis

GLP-1 Drugs Tied to Lower Addiction Risk

In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.